209 related articles for article (PubMed ID: 22004672)
21. Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry.
Thieme D; Sachs H; Uhl M
Drug Test Anal; 2014; 6(1-2):112-8. PubMed ID: 24424857
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
23. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
[TBL] [Abstract][Full Text] [Related]
24. Testing for Drugs in Exhaled Breath Collected With ExaBreath in a Drug Dependence Population: Comparison With Data Obtained in Urine After Liquid Chromatographic-Tandem Mass Spectrometric Analyses.
Kintz P; Mathiaux F; Villéger P; Gaulier JM
Ther Drug Monit; 2016 Feb; 38(1):135-9. PubMed ID: 26222873
[TBL] [Abstract][Full Text] [Related]
25. Cannabis Use Surveillance by Sweat Analysis.
Gambelunghe C; Fucci N; Aroni K; Bacci M; Marcelli A; Rossi R
Ther Drug Monit; 2016 Oct; 38(5):634-9. PubMed ID: 27465974
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.
De Cock KJ; Delbeke FT; De Boer D; Van Eenoo P; Roels K
J Anal Toxicol; 2003 Mar; 27(2):106-9. PubMed ID: 12670005
[TBL] [Abstract][Full Text] [Related]
27. Detection of 11-nor-9-carboxy-tetrahydrocannabinol in the hair of drug abusers by LC-MS/MS analysis.
Cho HS; Cho B; Sim J; Baeck SK; In S; Kim E
Forensic Sci Int; 2019 Feb; 295():219-225. PubMed ID: 30600116
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial of a new technique for drugs of abuse testing: a new possible sampling technique.
Skoglund C; Hermansson U; Beck O
J Subst Abuse Treat; 2015 Jan; 48(1):132-6. PubMed ID: 25312474
[TBL] [Abstract][Full Text] [Related]
29. Detection of in utero cannabis exposure by umbilical cord analysis.
Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
[TBL] [Abstract][Full Text] [Related]
30. Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid.
Toennes SW; Schneider K; Wunder C; Kauert GF; Moeller MR; Theunissen EL; Ramaekers JG
J Anal Toxicol; 2013 Apr; 37(3):152-8. PubMed ID: 23429905
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids in exhaled breath following controlled administration of smoked cannabis.
Himes SK; Scheidweiler KB; Beck O; Gorelick DA; Desrosiers NA; Huestis MA
Clin Chem; 2013 Dec; 59(12):1780-9. PubMed ID: 24046200
[TBL] [Abstract][Full Text] [Related]
32. Exhaled breath for drugs of abuse testing - evaluation in criminal justice settings.
Beck O
Sci Justice; 2014 Jan; 54(1):57-60. PubMed ID: 24438778
[TBL] [Abstract][Full Text] [Related]
33. Topical review on monitoring tetrahydrocannabinol in breath.
Mirzaei H; O'Brien A; Tasnim N; Ravishankara A; Tahmooressi H; Hoorfar M
J Breath Res; 2020 May; 14(3):034002. PubMed ID: 31842004
[TBL] [Abstract][Full Text] [Related]
34. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
35. Method validation and application of a liquid chromatography-tandem mass spectrometry method for drugs of abuse testing in exhaled breath.
Stephanson N; Sandqvist S; Lambert MS; Beck O
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():189-96. PubMed ID: 25687804
[TBL] [Abstract][Full Text] [Related]
36. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.
Westin AA; Huestis MA; Aarstad K; Spigset O
J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136
[TBL] [Abstract][Full Text] [Related]
37. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency.
Hädener M; Weinmann W; Schürch S; König S
Anal Bioanal Chem; 2016 Mar; 408(7):1953-62. PubMed ID: 26781107
[TBL] [Abstract][Full Text] [Related]
38. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
39. Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair.
Moore C; Rana S; Coulter C; Feyerherm F; Prest H
J Anal Toxicol; 2006 Apr; 30(3):171-7. PubMed ID: 16803651
[TBL] [Abstract][Full Text] [Related]
40. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
